Clinical Study on Effect of Medicine Separated Moxibustion on Shenque Eight Point Array Combined with Somatostatin in the Treatment of Early Postoperative Inflammatory Intestinal Obstruction

OBJECTIVE To observe the clinical effect of medicine separated moxibustion on shenque eight-point array combined with somatostatin in the treatment of early postoperative inflammatory intestinal obstruction (EPII). METHODS 76 patients were divided into the treatment group and the control group， 38 cases in each group. Both groups received routine nursing and treatment. The control group was treated with somatostatin (continuous infusion at 0.25 mg/h). On the basis of the control group， the treatment group was also given medicine separated moxibustion on shenque eight-point array. Main symptoms， intestinal function， serum C reactive protein (CRP)， tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6) levels were observed after 7 d of treatment， and the clinical effects were recorded. RESULTS The total clinical effective rates in the treatment group and the control group were 92.11% and 78.95%， respectively， P<0.05. Intestinal function， serum CRP， TNF-α and IL-6 levels of the treatment group were lower than those of the control group after the treatment， P<0.01. CONCLUSIONS Medicine separated moxibustion on eight-point array combined with somatostatin can significantly improve postoperative clinical symptoms of EPII patients， and effectively regulate serum CRP， TNF-α and IL-6 levels.